Smith Brandon S. 4
4 · PROTHENA CORP PUBLIC LTD CO · Filed Jul 12, 2023
Insider Transaction Report
Form 4
Smith Brandon S.
Chief Operating Officer
Transactions
- Sale
Ordinary Shares, par value $0.01 per share
2023-07-12$67.40/sh−3,200$215,667→ 800 total - Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2023-07-12$11.12/sh+4,000$44,480→ 4,000 total - Sale
Ordinary Shares, par value $0.01 per share
2023-07-12$67.95/sh−800$54,358→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-07-12−4,000→ 230,667 totalExercise: $11.12Exp: 2030-03-02→ Ordinary Shares (4,000 underlying)
Footnotes (4)
- [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.
- [F2]The transaction was executed in multiple trades in prices ranging from $66.815 to $67.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4.
- [F3]The transaction was executed in multiple trades in prices ranging from $67.855 to $68.295, inclusive.
- [F4]The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on March 2, 2021, and will vest with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.